S49076
WebSep 5, 2013 · S49076 inhibits autophosphorylation of these RTKs and their downstream signaling in vitro and in vivo, blocks growth and migration of MET-, AXL- and FGFR … Webs49076 hcl 是 met、axl/mer 和 fgfr1/2/3 的有效抑制剂。 s49076 在体外和体内有效阻断 met、axl 和 fgfr 的细胞磷酸化并抑制下游信号传导。在细胞模型中，s49076 抑制 met 和 fgfr2 依赖性胃癌细胞的增殖，阻断 met 驱动的肺癌细胞迁移，并抑制表达 fgfr...
S49076
Did you know?
WebS49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM. For research use only. We do not sell to patients. S49076 Chemical Structure CAS … Webs49076 是一种新型 met、axl/mer 和 fgfr1/2/3 高效抑制剂，ic50<20 nm。 jnj-38877605 t6095. jnj38877605 是 atp竞争性 c-met 抑制剂 (ic50:4 nm)，对c-met的抑制性比对其它 200 种酪氨酸和丝氨酸-苏氨酸激酶的抑制性高 600 倍。 ...
WebBurbridge MF, et al. S49076 is a novel kinase inhibitor of MET, 4、AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Mol Cancer Ther. 2013 Sep;12(9):1749-62.McePdfHeightCaution: Product has not been fully validated for medical applications. For research use only.Tel: 400-820-3792; 021-58955995 Fax: 021 ... WebCombination of S49076 and gefitinib is well tolerated and safety data are consistent with the overall safety profile of each drug. The phase II part of this study will start once the RP2D is defined to evaluate the anti-tumour activity of the combination." P1/2 data • Non Small Cell Lung Cancer Print Email More sharing September 01, 2024
WebS49076 potently blocked cellular phosphorylation of MET, AXL, FGFRs and inhibited downstream signaling in vitro and in vivo. In cell models, S49076 inhibited the … WebBackground and objectives: S49076 is a novel ATP-competitive tyrosine kinase inhibitor of MET, AXL and FGFR with a unique selectivity profile. A phase I open-label study was …
WebAug 1, 2024 · S49076 is a novel ATP-competitive tyrosine kinase inhibitor (TKI) that inhibits autophosphorylation and downstream signalling of MET, AXL and FGFR1/2/3 [9]; it lacks significant activity against vascular endothelial growth factor receptor 2 …
WebAug 1, 2024 · S49076 is a novel ATP-competitive tyrosine kinase inhibitor (TKI) that inhibits autophosphorylation and downstream signalling of MET, AXL and FGFR1/2/3 [9]; it lacks … great wakering populationWebFind many great new & used options and get the best deals for STAR WARS SCOUT TROOPER SW/S49-076 C WEISS SCHWARZ CARD LUCASFILM JAPANESE at the best … great wakering post office opening timesWebJul 15, 2016 · S49076 also inhibited the anchorage-independent growth and migration of the resistant cell lines. A correlation was found between mRNA and protein levels of AXL and sensitivity to S49076. Also, PARP cleavage and moderate but reproducible inhibition of AKT phosphorylation by S49076 were observed exclusively in the non-T790M resistant cell lines. florida department of child support eservicesWebJul 15, 2024 · Generic Name S-49076 DrugBank Accession Number DB16821 Background Not Available Type Small Molecule Groups Investigational Structure 3D Download Similar … florida department of bprWebAug 1, 2015 · Abstract. S49076 is an oral ATP-competitive inhibitor of the receptor tyrosine kinases MET, AXL, and FGFR1-3 currently in phase I/II clinical development in patients with advanced solid tumors. Here, we investigated the effect of S49076 on both MET- and non-MET- dependent cell lines alone and in association with ionizing radiation (IR) both in vitro … florida department of bankingWebMar 6, 2014 · TITANIUM ALLOY FORGINGS 6Al - 2Sn - 4Zr - 2Mo Solution and Precipitation Heat Treated AMS4976 – available for purchase at $54.00. Find the right standards and … florida department highway safetyWebCombination of S49076 and gefitinib is well tolerated and safety data are consistent with the overall safety profile of each drug. The phase II part of this study will start once the RP2D … great wakering primary